.jpg)
.png)
All
Overview Travel Grants and Awards E-Poster Submission Details FAQs GENERAL Who can submit an abstract? Anyone engaged in clinical practice, research, or education in lipidology or related fields may submit an abstract. Submissions must be made by the presenting author (or a co-author... more
The National Lipid Association has featured highlights from selected presentations at the 2017 Fall Clinical Lipid Update in Indianapolis. Read our meeting coverage here.
From HealthIT.gov: As part of an ongoing effort to empower patients to be informed partners with their health care providers, the Department of Health and Human Services (HHS) has taken action to give patients or a person designated by the patient a means of direct access to the patient’s... more
Arrowhead Pharmaceuticals is proud to announce the publication of two back-to-back NEJM manuscripts in the mixed hyperlipidemia population with plozasiran (MUIR study with APOC3 target) and zodasiran (ARCHES2 study with ANGPTL3 target) following the EAS presentations by Drs. Ballantyne and... more
View the NLA & Chapter Board Resrouces below: 2020-2021 Board Resource Packet Orientation Webinar Orientation Webinar Slides × Close
Over 26 million Americans have chronic kidney disease (CKD). At risk for CKD include 65 million Americans with hypertension and 20 million patients with diabetes mellitus. The risk of cardiovascular disease (CVD), including coronary, cerebrovascular, peripheral vascular disease, and congestive... more
Atherosclerosis is a lipid-driven disorder and the main underlying cause of cardiovascular disease (CVD).1 Microbiology has long been a critical focal area of medicine in terms of the effect of bacterial organisms on health and disease. What is the contemporary view of the relationship between... more
Following a June 2015 recommendation by the U.S Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee, the FDA has approved alirocumab for patients on maximally tolerated statin therapy with heterozygous familial hypercholesterolemia (HeFH) or with clinical... more